908devices. 2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export 908 Devices. 5,395 followers. 1w. Detection and identification of substances like fentanyl and xylazine at trace levels minimize harmful exposure while allowing the user to rapidly assess threat ...908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43…About MASS. 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of ...Nov 14, 2022 · BOSTON–(BUSINESS WIRE)–. 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to support our customers ... 908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook 05.09.23 908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...Q3 2022 revenue increases 26% over prior year, with gross margin of 59% BOSTON–(BUSINESS WIRE)– 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to ...908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00.BOSTON, May 30, 2023--908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for... 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00.908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43…908 Devices David Malone Current Workplace David Malone has been working as a Assistant Engineer at 908 Devices for 2 years. 908 Devices is part of the Manufacturing industry, and located in Massachusetts, United States. 908 Devices Location 645 Summer St, Boston, Massachusetts, 02210, United States Description Industry908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. warburgpincusinspiration capitalhudson furniture florida 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm)May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... 2 days ago · 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More sonobi Q3 2022 revenue increases 26% over prior year, with gross margin of 59% BOSTON–(BUSINESS WIRE)– 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to ... vertical holdings 908 Devices Research Services Boston, Massachusetts 5,395 followers See jobs Follow View all 221 employees Overview Jobs Life About us 908 Devices is revolutionizing chemical and biochemical... 2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export intentsify crunchbaseKenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More2 days ago · 908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Bringing the powerful capabilities of #MassSpectrometry out of the confines of centralized laboratories for analysis wherever and whenever it is needed insignia capital “Mass spectrometry is a powerful chemical measurement tool which can provide a lot of molecular specificity – right down to the exact molecule you’re detecting,” says Mike Ramsey, 908 Devices scientific founder and Minnie N. Goldby Distinguished Professor of Chemistry.Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More “Mass spectrometry is a powerful chemical measurement tool which can provide a lot of molecular specificity – right down to the exact molecule you’re detecting,” says Mike Ramsey, 908 Devices scientific founder and Minnie N. Goldby Distinguished Professor of Chemistry.About About See all 645 Summer St Boston, MA 02210 We make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. Found 14 of over 14 reviews Sort Popular Popular Most Recent Highest Rating908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...Our Vision. We are reimagining where Mass Spec can be used if it is sufficiently small in size, low in cost and simple to operate. We believe the insights and answers our devices … infinit healthcare BOSTON, May 30, 2023--908 Devices Inc (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, is showcasing its ZipChip CE-MS device for... Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read MoreCustomers, including the Minnesota Department of Corrections, are leveraging the MX908 handheld device to keep correctional officers and inmates safe from drug exposure and prevent overdoses 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today shared details on the positive impact of the MX908 handheld ... canalbank Our Vision. We are reimagining where Mass Spec can be used if it is sufficiently small in size, low in cost and simple to operate. We believe the insights and answers our devices …Our Vision. We are reimagining where Mass Spec can be used if it is sufficiently small in size, low in cost and simple to operate. We believe the insights and answers our devices … call em all Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. dales truck sales 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. duns id BCTNP ... bctnp Revenue of $11.6 million for the fourth quarter 2022, compared to $15.8 million in the fourth quarter 2021, which included an $8 million shipment of MX908 devices to …908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm)908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. novos gg Mar 31, 2021 · 908 Devices Inc. - 908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook TECH NOTE 4.0 Using the ZipChip infusion function OVERVIEW The v1.3.0 release of the ZipChip software gives users the ability to use their existing ZipChip system as a static nano-spray source to infuse sample for extended ESI-MS.908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm) data machine Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... onbe Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. BCTNP ... bctnp BOSTON, August 09, 2022 -- ( BUSINESS WIRE )-- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today...908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... dmetrain Customers, including the Minnesota Department of Corrections, are leveraging the MX908 handheld device to keep correctional officers and inmates safe from drug exposure and prevent overdoses 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today shared details on the positive impact of the MX908 handheld ...2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... lewisburg container 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...Find it. Even at trace levels. MX908 detects compounds at trace levels with a high level of sensitivity and unparalleled selectivity, giving you actionable intelligence that other … forecomm If you're a small business in need of assistance, please contact [email protected]
908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm)High Pressure Mass Spectrometry | Technology | 908 Devices Technology Analysis For Life Our point-of-need handheld and desktop devices … starfish bus company Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More The ZipChip® system is a microfluidic device that integrates capillary electrophoresis (CE) with electrospray ionization. The system employs zone electrophoresis, where analytes are injected as a small band and are then separated in an electric field.908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution …908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... 2400 yorkmont rd Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. Mar 31, 2021 · 908 Devices Inc. - 908 Devices Reports First Quarter 2022 Financial Results and Reiterates 2022 Revenue Outlook ventra ionia May 9, 2023 · 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -11.43%. 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43… bahwan cyber tek 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...Bring ‘em on. ZipChip doesn’t even flinch at matrices with detergents or salt, making it the ideal solution for biopharma samples. ZipChip CE-Mass spectrometry is the perfect orthogonal alternative to LC/MS. Trusted by … boost payment solutions 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43…[email protected]. source. More Resources Customer Service Portal. General Inquiries. call. Phone +1.857.254.1500. 8am–5pm EST. Mon – Fri . place. Our …908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ...BOSTON, August 09, 2022 -- ( BUSINESS WIRE )-- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today... action finance inc908 Devices Aug 2021 - Present1 year 11 months Research Triangle Park, North Carolina Adjunct Assistant Professor Duke University School of …908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... May 30, 2023 · 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the ... k gas oroville 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. kigen WWW.908DEVICES.COM/REBEL REBEL is subject to export controls including those of the Export Administration Regulations of the U.S. Department of Commerce, which may restrict or require licenses for the export of product from the United States and their re-export to and from other countries.908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More Jun 4, 2023 · Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More hunington properties BOSTON, May 04, 2023 -- ( BUSINESS WIRE )-- 908 Devices Inc ., (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announced the release...908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution …908 Devices had revenue of $9.49M in the quarter ending March 31, 2023 with 14.22% year-over-year growth. This brings the trailing twelve month (ttm) revenue to $48.03M, up 6.81% year-over-year. In the year 2022, 908 Devices had annual revenue of $46.85M with 11.01% growth. Revenue (ttm) universal well services 908 Devices @908Devices 13h MX908 users can conduct field analysis of unknown substances at trace levels to assess threat levels, establish probable cause and prioritize investigatory resources …Nov 14, 2022 · BOSTON–(BUSINESS WIRE)–. 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today reported financial results for the quarter ended September 30, 2022. “We were pleased with our results for the third quarter as we continue to support our customers ... Kenan Smith is a Shipping Receiving Coordinator at 908 Devices based in Boston, Massachusetts. Previously, Kenan was an Inventory Specialist at Fo undation Medicine. Read More claridge association Jun 6, 2023 · 908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. josh packaging About About See all 645 Summer St Boston, MA 02210 We make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices. Full Year 2022 revenue increases 11% compared to prior year with desktop revenue increasing 25% 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, today reported financial results for the quarter and full year ended December 31, 2022. “While we are pleased with the progress made against our long-term objectives in ... business revenue lookup 908 Devices @908Devices 13h MX908 users can conduct field analysis of unknown substances at trace levels to assess threat levels, establish probable cause and prioritize investigatory resources …908 Devices Reports First Quarter 2023 Financial Results and Reiterates 2023 Revenue Outlook 05.09.23 908 Devices Launches Data Analysis Visualization Tool for REBEL At-line Cell Culture Media Analyzer908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ... hacker ranker 908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of ...2 days ago · $48.03M Revenue Growth +6.81% P/S Ratio 6.11 Revenue / Employee $211,599 Employees 227 Market Cap 293.63M Revenue Chart 908 Devices Revenue - Annual 2019 2020 2021 2022 2023 - 10M 20M 30M 40M 5Y 10Y Max Revenue History Annual Export Apr 2, 2019 · With roots at the University of North Carolina at Chapel Hill, 908 Devices is a pioneer of purpose-built analytical devices for chemical and biomolecular analysis. Over the past few years, 908 Devices has quietly advanced from a startup to a nearly 100-employee company – making an impact through its work in chemical and biomolecular analysis. 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company's devices are used at the point ...908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, … a and a bolt and screw 908 Devices is revolutionizing chemical and biochemical analysis with its mass spec devices that are simple to operate, provide answers in minutes and are used at the point of need. The company's ... 908 Devices Inc manufactures medical devices. It has developed an innovative suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Bring ‘em on. ZipChip doesn’t even flinch at matrices with detergents or salt, making it the ideal solution for biopharma samples. ZipChip CE-Mass spectrometry is the perfect orthogonal alternative to LC/MS. Trusted by …908 Devices Price Performance. 908 Devices stock opened at $9.13 on Tuesday. The firm has a 50 day simple moving average of $8.04 and a 200-day simple moving average of $8.63. The stock has a market capitalization of $293.62 million, a PE ratio of -7.87 and a beta of 0.58. 908 Devices Inc. has a 12-month low of $5.69 and a 12-month high of $26.00. ims rochester office 908 Devices is revolutionizing chemical and biochemical analysis with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the [email protected] | 908Devices.com PTIONS Report format: CSV and PDF Betaine Alanyl-glutamine Aspartic acid Glutamic acid Histidine Lysine Proline ryptophan.“Mass spectrometry is a powerful chemical measurement tool which can provide a lot of molecular specificity – right down to the exact molecule you’re detecting,” says Mike Ramsey, 908 Devices scientific founder and Minnie N. Goldby Distinguished Professor of Chemistry. goldmark federal credit union WWW.908DEVICES.COM/REBEL REBEL is subject to export controls including those of the Export Administration Regulations of the U.S. Department of Commerce, which may restrict or require licenses for the export of product from the United States and their re-export to and from other countries.Feb 7, 2012 · 908 Devices @908Devices Bringing the powerful capabilities of #MassSpectrometryout of the confines of centralized laboratories for analysis wherever and whenever it is needed Science & TechnologyBoston, MA908devices.comJoined February 2012 382Following 960Followers Tweets Replies Media Likes 908 Devices’s Tweets 908 Devices @908Devices 13h king kong agency 908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -11.43… parbel 908 Devices Inc. (NASDAQ:MASS – Get Rating) CTO Christopher D. Brown sold 10,000 shares of the firm’s stock in a transaction on Wednesday, July 6th. The shares were sold at an average price of $21.28, for a total value of $212,800.00. Following the sale, the chief technology officer now directly owns 928,912 shares of the […] Jul 10, 2022.About MASS. 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.Customers, including the Minnesota Department of Corrections, are leveraging the MX908 handheld device to keep correctional officers and inmates safe from drug exposure and prevent overdoses 908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today shared details on the positive impact of the MX908 handheld ...We make point-of-need-devices ranging from rugged, handheld chemical detection tools to compact,... 645 Summer St, Boston, MA 02210 quadreal property group
Solutions from 908devices, Inc. Yellow Pages directories can mean big success stories for your. 908devices White Pages are public records which are documents or pieces of information that are not considered confidential and can be viewed instantly online. me/908devices If you're a small business in need of assistance, please contact [email protected]